In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple β-lactamases
- 31 October 2008
- journal article
- case report
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 32 (4), 302-307
- https://doi.org/10.1016/j.ijantimicag.2008.02.014
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Molecular Epidemiology of Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases in a French HospitalJournal of Clinical Microbiology, 2004
- Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenesBiochemical and Biophysical Research Communications, 2004
- Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care CentersAntimicrobial Agents and Chemotherapy, 2003
- Outbreak of TEM-24-ProducingEnterobacter aerogenesin a Spanish HospitalMicrobial Drug Resistance, 2003
- Imipenem and expression of multidrug efflux pump in Enterobacter aerogenesBiochemical and Biophysical Research Communications, 2003
- Carbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin AnalogsAntimicrobial Agents and Chemotherapy, 2002
- Coexistence of SHV-4- and TEM-24-Producing Enterobacter aerogenes Strains before a Large Outbreak of TEM-24-Producing Strains in a French HospitalJournal of Clinical Microbiology, 2001
- National Epidemiologic Surveys of Enterobacter aerogenes in Belgian Hospitals from 1996 to 1998Journal of Clinical Microbiology, 2001
- TEM-24 extended-spectrum β-lactamase-producing Enterobacter aerogenes: long-term clonal dissemination in French hospitalsClinical Microbiology & Infection, 2000
- Epidemiology of infections due to multiresistantEnterobacter aerogenes in a University HospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996